New location in Destin expands the Company's retail presence
to 64 dispensaries in Florida and
150 nationwide
STAMFORD, Conn., Aug. 14,
2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX:
CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading
international provider of consumer cannabis products, today
announced it will open a new medical dispensary in Destin, Florida. Curaleaf Destin, located at
34761 Emerald Parkway, Suite #02, Destin,
FL 32541, opens Wednesday, August
14. The Company's latest expansion in the Sunshine State
will increase its retail footprint to 64 retail locations statewide
and 150 nationwide.
Curaleaf Destin is the Company's first medical dispensary in
Okaloosa County, servicing the
area's scenic coastline that stretches alongside Henderson Beach
State Park. The Company's latest expansion will reach more patients
in northwest Florida, providing
access to a wide selection of cannabis products and brands,
including the new Select Fruit STIQ all-in-one vape, JAMS edibles,
Grassroots, B NOBLE, and the Company's all-in-one two gram vape,
Select BRIQ.
Curaleaf Destin will operate from 9:00
a.m. to 8:30 p.m. CT Monday through Saturday and
10:00 a.m. to 7:00 p.m. CT on Sunday
and will feature knowledgeable staff members to guide patients
during their visit.
"We are thrilled to broaden our reach in Florida as we open up our latest dispensary
beachside in Destin," said
Matt Darin, CEO of Curaleaf. "We are
committed to the expansion of our retail presence in Florida, proudly bringing our total retail
footprint to 64 dispensaries statewide and 150 nationwide. It's
been clear to us since we began serving the Florida medical market in 2016 that this state
appreciates and values access to tested, regulated cannabis. We
support Amendment 3 in Florida, as
do the majority of voters, and are prepared to provide widespread
access to adult-use cannabis."
In celebration, Curaleaf Destin will host grand opening events
on Friday, September 6. Live music,
prizes, and special discounts will be available for medical
patients as Curaleaf commemorates the launch of its newest cannabis
communities in Florida.
For more information on Curaleaf's locations, patient resources,
delivery program, and products in Florida, please visit
https://curaleaf.com/dispensary/florida.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX:
CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international
provider of consumer products in cannabis with a mission to enhance
lives by cultivating, sharing and celebrating the power of the
plant. As a high-growth cannabis company known for quality,
expertise and reliability, the Company and its brands, including
Curaleaf, Select, Grassroots, JAMS, Find, Zero Proof and The Hemp
Company provide industry-leading service, product selection and
accessibility across the medical and adult use markets. Curaleaf
International is the largest vertically integrated cannabis company
in Europe with a unique supply and
distribution network throughout the European market, bringing
together pioneering science and research with cutting-edge
cultivation, extraction and production. Curaleaf is listed on the
Toronto Stock Exchange under the symbol CURA and trades on the
OTCQX market under the symbol CURLF. For more information, please
visit https://ir.curaleaf.com.
Forward Looking Statements:
This media advisory
contains forward-looking statements and forward-looking information
within the meaning of applicable securities laws. These statements
relate to future events or future performance. All statements other
than statements of historical fact may be forward–looking
statements or information. Generally, forward-looking statements
and information may be identified by the use of forward-looking
terminology such as "plans", "expects" or "proposed", "is
expected", "intends", "anticipates", or "believes", or variations
of such words and phrases, or by the use of words or phrases which
state that certain actions, events or results may, could, would, or
might occur or be achieved. More particularly and without
limitation, this news release contains forward-looking statements
and information concerning the opening of the Company's
Destin, Florida location. Such
forward-looking statements and information reflect management's
current beliefs and are based on assumptions made by and
information currently available to the company with respect to the
matter described in this new release. Forward-looking statements
involve risks and uncertainties, which are based on current
expectations as of the date of this release and subject to known
and unknown risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such
statements. Additional information about these assumptions and
uncertainties is contained under "Risk Factors and Uncertainties"
in the Company's latest annual information form filed on
March 6, 2024, which is available
under the Company's SEDAR profile at http://www.sedar.com, and in
other filings that the Company has made and may make with
applicable securities authorities in the future. Forward-looking
statements contained herein are made only as to the date of this
press release and we undertake no obligation to update or revise
any forward-looking statements whether as a result of new
information, future events or otherwise, except as required by law.
We caution investors not to place considerable reliance on the
forward-looking statements contained in this press release. The
Toronto Stock Exchange has not reviewed, approved or disapproved
the content of this news release.
Contacts:
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment
Officer
IR@curaleaf.com
Media Contact:
Curaleaf Holdings, Inc.
Jordon Rahmil, VP Public Relations
media@curaleaf.com
View original
content:https://www.prnewswire.com/news-releases/curaleaf-announces-the-opening-of-new-dispensary-in-destin-florida-302221846.html
SOURCE Curaleaf Holdings, Inc.